winona semaglutide Novo Nordisk's weight-loss pill wins FDA approval Novo Nordisk expands Wegovy access

For patients who don't meet that threshold or want to skip the PA process, Curex offers compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) no insurance, no prior authorization

Key facts CVS Caremark made Wegovy the preferred weight-loss GLP-1 effective July 1, 2025, benefiting Aetna commercial members while Express Scripts (Cigna) excludes it on the base formulary

Skibicka KP (2013) The central GLP-1: implications for food and drug reward

The cardiovascular burden of lupus SLE patients face a two to three fold increased risk of cardiovascular events compared to the general population

Semaglutide and tirzepatide are used as active pharmaceutical ingredients in FDA-approved brand-name products - Wegovy, Ozempic, Mounjaro, and Zepbound